The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Gaalen, F.
Right arrow Articles by Toes, R. E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Gaalen, F.
Right arrow Articles by Toes, R. E. M.
The Journal of Immunology, 2005, 175: 5575-5580.
Copyright © 2005 by The American Association of Immunologists


BRIEF REVIEWS

The Devil in the Details: The Emerging Role of Anticitrulline Autoimmunity in Rheumatoid Arthritis

Floris van Gaalen, Andreea Ioan-Facsinay, Tom W. J. Huizinga and René E. M. Toes1

Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands

Rheumatoid arthritis is a chronic inflammatory autoimmune disease of unknown cause. The immune response against citrullinated Ags has recently become the prime suspect for disease pathogenesis. Immunity against citrullinated Ags is thought to play a pivotal role in the disease for several reasons: 1) citrullinated Ags are expressed in the target organ, the inflamed joint; 2) anti-citrullinated protein Abs are present before the disease becomes manifest; and 3) these Abs are highly specific for rheumatoid arthritis. In this review, data from clinical, genetic, biochemical, and animal studies is combined to create a profile of this remarkable autoantibody response. Moreover, a model is proposed of how the anti-citrullinated proteins response is generated and how it could eventually lead to chronic inflammation.




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
D M Lee, R Phillips, E M Hagan, L B Chibnik, K H Costenbader, and P H Schur
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis
Ann Rheum Dis, February 1, 2009; 68(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Orozco, D. Pascual-Salcedo, M. A. Lopez-Nevot, T. Cobo, A. Cabezon, E. Martin-Mola, A. Balsa, and J. Martin
Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis
Rheumatology, February 1, 2008; 47(2): 138 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Banda, K. Takahashi, A. K. Wood, V. M. Holers, and W. P. Arend
Pathogenic Complement Activation in Collagen Antibody- Induced Arthritis in Mice Requires Amplification by the Alternative Pathway
J. Immunol., September 15, 2007; 179(6): 4101 - 4109.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
B. Rodriguez-Bayona, J. J. Perez-Venegas, C. Rodriguez, and J. A. Brieva
CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints
Rheumatology, April 1, 2007; 46(4): 612 - 616.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. Wesoly, X. Hu, M. M. Thabet, M. Chang, H. Uh, C. F. Allaart, R. E. M. Toes, J. J. Houwing-Duistermaat, A. B. Begovich, and T. W. J. Huizinga
The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population
Rheumatology, April 1, 2007; 46(4): 617 - 621.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Hvatum, L Kanerud, R Hallgren, and P Brandtzaeg
The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis
Gut, September 1, 2006; 55(9): 1240 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. K. Banda, J. M. Thurman, D. Kraus, A. Wood, M. C. Carroll, W. P. Arend, and V. M. Holers
Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis
J. Immunol., August 1, 2006; 177(3): 1904 - 1912.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.